Supernus Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Supernus Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.9M | 65k | 28.94 |
2023-09-30 | $525k | 19k | 27.57 |
2023-06-30 | $1.6M | 54k | 30.05 |
2023-03-31 | $1.4M | 40k | 36.23 |
2022-12-31 | $1.0M | 28k | 35.67 |
2022-09-30 | $258k | 7.5k | 34.17 |
2022-06-30 | $45k | 1.6k | 28.38 |
2022-03-31 | $2.6M | 84k | 30.61 |
2021-12-31 | $2.9M | 99k | 29.02 |
2021-09-30 | $82k | 3.0k | 26.74 |
2021-06-30 | $744k | 24k | 30.83 |
2021-03-31 | $4.6M | 175k | 26.18 |
2020-12-31 | $4.6M | 181k | 25.16 |
2020-09-30 | $351k | 17k | 20.93 |
2020-06-30 | $707k | 30k | 23.79 |
2020-03-31 | $734k | 41k | 17.98 |
2019-12-31 | $1.3M | 54k | 23.73 |
2019-09-30 | $4.5M | 163k | 27.48 |
2019-06-30 | $23M | 696k | 33.09 |
2019-03-31 | $23M | 676k | 34.56 |
2018-12-31 | $12M | 351k | 33.23 |
2018-09-30 | $16M | 323k | 50.31 |
2018-06-30 | $1.8M | 30k | 59.86 |
2018-03-31 | $657k | 14k | 45.80 |
2017-12-31 | $548k | 14k | 40.00 |
2017-09-30 | $1.8M | 45k | 40.00 |
2017-06-30 | $2.6M | 61k | 43.10 |
2017-03-31 | $1.9M | 61k | 31.31 |
2016-12-31 | $505k | 20k | 25.24 |
2016-09-30 | $685k | 28k | 24.72 |
2016-06-30 | $93k | 4.5k | 20.67 |
2016-03-31 | $69k | 4.5k | 15.33 |
2015-12-31 | $698k | 52k | 13.44 |
2015-09-30 | $705k | 50k | 14.04 |
2015-03-31 | $544k | 45k | 12.18 |